Cargando…
Evaluation of the synergistic effects of epigallocatechin-3-gallate-loaded PEGylated-PLGA nanoparticles with nimodipine against neuronal injury after subarachnoid hemorrhage
Subarachnoid hemorrhage (SAH) is a devastating subtype of stroke with high mortality and morbidity. Although serious side effects might occur, nimodipine, a second-generation 1,4-dihydropyridine calcium channel blocker, is clinically used to improve neurological outcomes after SAH. Recently, (-)-epi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845867/ https://www.ncbi.nlm.nih.gov/pubmed/36687668 http://dx.doi.org/10.3389/fnut.2022.953326 |
_version_ | 1784871012794368000 |
---|---|
author | Yang, Xianguang Han, Mengguo Wang, Xue Wang, Jian Sun, Xiaoxue Zhang, Chunyan Yan, Shuaiguo Huang, Liyong Chen, Ying |
author_facet | Yang, Xianguang Han, Mengguo Wang, Xue Wang, Jian Sun, Xiaoxue Zhang, Chunyan Yan, Shuaiguo Huang, Liyong Chen, Ying |
author_sort | Yang, Xianguang |
collection | PubMed |
description | Subarachnoid hemorrhage (SAH) is a devastating subtype of stroke with high mortality and morbidity. Although serious side effects might occur, nimodipine, a second-generation 1,4-dihydropyridine calcium channel blocker, is clinically used to improve neurological outcomes after SAH. Recently, (-)-epigallocatechin-3-gallate (EGCG) has been reported to inhibit Ca(2+) overloading-induced mitochondrial dysfunction, oxidative stress, and neuronal cell death after SAH; however, low bioavailability, instability, and cytotoxicity at a high dose limited the clinical application of EGCG. To overcome these limitations, PEGylated-PLGA EGCG nanoparticles (EGCG-NPs) were constructed to enhance the bioavailability by using the double-emulsion method. Antioxidative activity, cytotoxicity, behavioral, and immunohistochemistry studies were carried out to determine the neuroprotective effectiveness after cotreatment with EGCG-NPs (75 mg/kg/d preconditioning for 7 days before SAH) and nimodipine (10 mg/kg/d after 30 min of SAH) by using in vivo SAH models. The optimized EGCG-NPs with a Box–Behnken design showed a small particle size of 167 nm, a zeta potential value of −22.6 mV, an encapsulation efficiency of 86%, and a sustained-release profile up to 8 days in vitro. Furthermore, EGCG-NPs (75 mg/kg/d) had superior antioxidative activity to free EGCG (100 mg/kg/d). EGCG-NPs combined with nimodipine exhibited significant synergistic effects against neuronal cell death by suppressing oxidative stress, Ca(2+) overloading, mitochondrial dysfunction, and autophagy after SAH. These results suggest that cotreatment with EGCG-NPs and nimodipine may serve as a promising novel strategy for the treatment of SAH. |
format | Online Article Text |
id | pubmed-9845867 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98458672023-01-19 Evaluation of the synergistic effects of epigallocatechin-3-gallate-loaded PEGylated-PLGA nanoparticles with nimodipine against neuronal injury after subarachnoid hemorrhage Yang, Xianguang Han, Mengguo Wang, Xue Wang, Jian Sun, Xiaoxue Zhang, Chunyan Yan, Shuaiguo Huang, Liyong Chen, Ying Front Nutr Nutrition Subarachnoid hemorrhage (SAH) is a devastating subtype of stroke with high mortality and morbidity. Although serious side effects might occur, nimodipine, a second-generation 1,4-dihydropyridine calcium channel blocker, is clinically used to improve neurological outcomes after SAH. Recently, (-)-epigallocatechin-3-gallate (EGCG) has been reported to inhibit Ca(2+) overloading-induced mitochondrial dysfunction, oxidative stress, and neuronal cell death after SAH; however, low bioavailability, instability, and cytotoxicity at a high dose limited the clinical application of EGCG. To overcome these limitations, PEGylated-PLGA EGCG nanoparticles (EGCG-NPs) were constructed to enhance the bioavailability by using the double-emulsion method. Antioxidative activity, cytotoxicity, behavioral, and immunohistochemistry studies were carried out to determine the neuroprotective effectiveness after cotreatment with EGCG-NPs (75 mg/kg/d preconditioning for 7 days before SAH) and nimodipine (10 mg/kg/d after 30 min of SAH) by using in vivo SAH models. The optimized EGCG-NPs with a Box–Behnken design showed a small particle size of 167 nm, a zeta potential value of −22.6 mV, an encapsulation efficiency of 86%, and a sustained-release profile up to 8 days in vitro. Furthermore, EGCG-NPs (75 mg/kg/d) had superior antioxidative activity to free EGCG (100 mg/kg/d). EGCG-NPs combined with nimodipine exhibited significant synergistic effects against neuronal cell death by suppressing oxidative stress, Ca(2+) overloading, mitochondrial dysfunction, and autophagy after SAH. These results suggest that cotreatment with EGCG-NPs and nimodipine may serve as a promising novel strategy for the treatment of SAH. Frontiers Media S.A. 2023-01-04 /pmc/articles/PMC9845867/ /pubmed/36687668 http://dx.doi.org/10.3389/fnut.2022.953326 Text en Copyright © 2023 Yang, Han, Wang, Wang, Sun, Zhang, Yan, Huang and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Nutrition Yang, Xianguang Han, Mengguo Wang, Xue Wang, Jian Sun, Xiaoxue Zhang, Chunyan Yan, Shuaiguo Huang, Liyong Chen, Ying Evaluation of the synergistic effects of epigallocatechin-3-gallate-loaded PEGylated-PLGA nanoparticles with nimodipine against neuronal injury after subarachnoid hemorrhage |
title | Evaluation of the synergistic effects of epigallocatechin-3-gallate-loaded PEGylated-PLGA nanoparticles with nimodipine against neuronal injury after subarachnoid hemorrhage |
title_full | Evaluation of the synergistic effects of epigallocatechin-3-gallate-loaded PEGylated-PLGA nanoparticles with nimodipine against neuronal injury after subarachnoid hemorrhage |
title_fullStr | Evaluation of the synergistic effects of epigallocatechin-3-gallate-loaded PEGylated-PLGA nanoparticles with nimodipine against neuronal injury after subarachnoid hemorrhage |
title_full_unstemmed | Evaluation of the synergistic effects of epigallocatechin-3-gallate-loaded PEGylated-PLGA nanoparticles with nimodipine against neuronal injury after subarachnoid hemorrhage |
title_short | Evaluation of the synergistic effects of epigallocatechin-3-gallate-loaded PEGylated-PLGA nanoparticles with nimodipine against neuronal injury after subarachnoid hemorrhage |
title_sort | evaluation of the synergistic effects of epigallocatechin-3-gallate-loaded pegylated-plga nanoparticles with nimodipine against neuronal injury after subarachnoid hemorrhage |
topic | Nutrition |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845867/ https://www.ncbi.nlm.nih.gov/pubmed/36687668 http://dx.doi.org/10.3389/fnut.2022.953326 |
work_keys_str_mv | AT yangxianguang evaluationofthesynergisticeffectsofepigallocatechin3gallateloadedpegylatedplgananoparticleswithnimodipineagainstneuronalinjuryaftersubarachnoidhemorrhage AT hanmengguo evaluationofthesynergisticeffectsofepigallocatechin3gallateloadedpegylatedplgananoparticleswithnimodipineagainstneuronalinjuryaftersubarachnoidhemorrhage AT wangxue evaluationofthesynergisticeffectsofepigallocatechin3gallateloadedpegylatedplgananoparticleswithnimodipineagainstneuronalinjuryaftersubarachnoidhemorrhage AT wangjian evaluationofthesynergisticeffectsofepigallocatechin3gallateloadedpegylatedplgananoparticleswithnimodipineagainstneuronalinjuryaftersubarachnoidhemorrhage AT sunxiaoxue evaluationofthesynergisticeffectsofepigallocatechin3gallateloadedpegylatedplgananoparticleswithnimodipineagainstneuronalinjuryaftersubarachnoidhemorrhage AT zhangchunyan evaluationofthesynergisticeffectsofepigallocatechin3gallateloadedpegylatedplgananoparticleswithnimodipineagainstneuronalinjuryaftersubarachnoidhemorrhage AT yanshuaiguo evaluationofthesynergisticeffectsofepigallocatechin3gallateloadedpegylatedplgananoparticleswithnimodipineagainstneuronalinjuryaftersubarachnoidhemorrhage AT huangliyong evaluationofthesynergisticeffectsofepigallocatechin3gallateloadedpegylatedplgananoparticleswithnimodipineagainstneuronalinjuryaftersubarachnoidhemorrhage AT chenying evaluationofthesynergisticeffectsofepigallocatechin3gallateloadedpegylatedplgananoparticleswithnimodipineagainstneuronalinjuryaftersubarachnoidhemorrhage |